Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 (IDP-118)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Dow Pharmaceutical Sciences.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Dow Pharmaceutical Sciences Identifier:
First received: May 31, 2012
Last updated: April 23, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)